SCHEMBL15480660

SCHEMBL15480660

O=C(O)c1c(NC(=O)C2CCC(C(F)(F)F)CC2)csc1-c1ccc(Br)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PI4KB Q9UBF8 1/20 0.41
▸ HDAC3 O15379 9/20 0.39
▸ HDAC1 Q13547 9/20 0.39
▸ HDAC2 Q92769 9/20 0.39
▸ CASP3 P42574 1/20 0.38
▸ SENP8 Q96LD8 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ GLA P06280 1/20 0.34
▸ CSNK2A2 P19784 1/20 0.34
▸ CSNK2A1 P68400 1/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ POLB P06746 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12756731 0.92 CASP3 (0.39) PI4KBHDAC3HDAC1HDAC2CASP3
SCHEMBL12830908 0.85 HDAC1 (0.46) HDAC3HDAC1HDAC2CASP3SENP8
SCHEMBL15258591 0.81 CASP3 (0.56) CASP3SENP8SENP7SENP6KMT2A
SCHEMBL12756734 0.79 NPY5R (0.39) HDAC3HDAC1HDAC2CASP3SENP8
SCHEMBL12756748 0.77 P2RX7 (0.41) HDAC3HDAC1HDAC2CASP3SENP8
SCHEMBL12756740 0.76 CASP3 (0.43) HDAC3HDAC1HDAC2CASP3SENP8
SCHEMBL12756738 0.74 ABL1 (0.56) HDAC3HDAC1HDAC2KMT2APOLB
SCHEMBL1490559 0.73 MEN1 (0.47) HDAC2KMT2AMEN1NPC1RAB9A
SCHEMBL12830925 0.73 MEN1 (0.47) HDAC2KMT2AMEN1NPC1RAB9A
SCHEMBL12830039 0.73 HDAC4 (0.47) NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 PI4KB 303/4885HDAC3 1653/4885HDAC1 2696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback